Login / Signup

Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease.

Anders LøkkeLuca CastelloPedro Pinheiro MartinsStéphane SoulardOle Hilberg
Published in: Advances in therapy (2023)
The impact of non-IPF PPF and SSc-ILD on society is definitely non-negligible. Actions to reduce the burden on our societies are highly needed.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • rheumatoid arthritis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • risk factors